Source: European Parliament
Priority question for written answer P-000773/2025
to the Commission
Rule 144
Stine Bosse (Renew), Vlad Vasile-Voiculescu (Renew), Catarina Martins (The Left), Sirpa Pietikäinen (PPE), Lena Schilling (Verts/ALE), Lucia Yar (Renew), Karin Karlsbro (Renew), Emma Wiesner (Renew), Abir Al-Sahlani (Renew), Romana Jerković (S&D), Tilly Metz (Verts/ALE), Maria Walsh (PPE), Olivier Chastel (Renew), Joanna Scheuring-Wielgus (S&D), Christine Singer (Renew), Barry Andrews (Renew), Sebastian Everding (The Left), Vicent Marzà Ibáñez (Verts/ALE), Veronika Cifrová Ostrihoňová (Renew), Sophie Wilmès (Renew), Kim Van Sparrentak (Verts/ALE), Raquel García Hermida-Van Der Walle (Renew), Benoit Cassart (Renew), Elisabeth Grossmann (S&D), Elena Kountoura (The Left), Rasmus Nordqvist (Verts/ALE), Villy Søvndal (Verts/ALE), Marit Maij (S&D), Charles Goerens (Renew), Marc Angel (S&D), Anna-Maja Henriksson (Renew), Isabella Lövin (Verts/ALE), Alice Kuhnke (Verts/ALE), Pär Holmgren (Verts/ALE)
The United States’ impending withdrawal from the WHO, its reinstatement of the Mexico City Policy and the abandonment of the pandemic prevention treaty present an urgent challenge both to Europe and the entire world at a time when global collaboration on anti-microbial resistance (AMR), HIV, and the promotion of sexual and reproductive health and rights (SRHR) is as important as ever.
- 1.Given Europe’s role as one of the principal WHO donors, what concrete steps will the Commission and the Vice-President of the Commission / High Representative of the Union for Foreign Affairs and Security Policy take to both step up EU action on global health financing and mitigate the likely harm to health in Europe and globally resulting from these decisions, and how will Europe seek to fill the global financing gap in the fight against HIV and in promoting SRHR?
- 2.Given the failure to agree on binding measures on AMR at the UN level, what specific actions will the Commission and the European External Action Service now take to bolster international efforts to combat AMR?
- 3.Will the Commission address AMR in the upcoming strategy for a Preparedness Union? If so, how will it complement ongoing initiatives such as the Health and Digital Executive Agency’s drug subscription pilot and the Health Emergency Preparedness and Response Authority’s plans to explore pull incentives?
Supporter[1]
Submitted: 19.2.2025
- [1] This question is supported by a Member other than the authors: Marie Toussaint (Verts/ALE)